Understanding the Link Between DNA Damage and Cognitive Decline in Progressive MS
For years, the medical community’s approach to multiple sclerosis (MS) has focused heavily on the immune system’s attack on myelin—the protective fatty insulation surrounding nerve fibers. While managing this inflammation is critical, it doesn’t fully explain the devastating cognitive decline seen in the progressive stages of the disease. New research is now uncovering why certain brain cells are uniquely vulnerable, offering a potential roadmap for treatments that could prevent the brain from shrinking and preserve memory and reasoning.
- CUX2 Neurons: A specific group of cells in the human cortex essential for cognition are highly susceptible to degeneration in progressive MS.
- The DNA Connection: These cells are prone to DNA damage due to their rapid multiplication during brain development.
- The ATF4 Protein: Researchers identified ATF4 as a critical “repair kit” protein that helps these cells survive initially.
- New Treatment Targets: The findings suggest that targeting the intrinsic vulnerabilities of nerve cells, rather than just inflammation, is essential for stopping cognitive decline.
The Role of CUX2 Neurons in Human Cognition
The human cortex, the brain’s outermost layer, contains a specialized group of neurons known as CUX2 neurons. These cells make up two specific layers of the cortex that drive computation and cognition—the highly processes that allow for complex reasoning and memory. Because of their role in these high-level functions, Steve Fancy, a neuroscientist at the University of California, San Francisco, notes that these layers are “really very essential for making us human.”
However, the very nature of how these cells are created makes them a liability. CUX2 cells multiply rapidly during brain development. While this speed is necessary for growth, it increases the risk of accruing DNA damage, leaving these neurons inherently fragile from the start.
How DNA Damage Drives Progressive MS
In two papers published in Nature on April 1, researchers detailed a mechanism that explains why these cells fail during the progressive phase of MS. The team identified a protein called ATF4, which acts as a cellular repair kit. ATF4 jump-starts the DNA repair response to prevent damage as neurons develop. When researchers disabled ATF4 in mice, the CUX2 neurons died quickly, underscoring the protein’s necessity for cell survival.
The research found that in humans with MS, the layers of the brain where CUX2 neurons reside show significantly higher levels of DNA damage compared to healthy brains. This suggests a “perfect storm” scenario: neurons that are already predisposed to DNA damage due to their developmental history cannot withstand the additional stress caused by MS-related inflammation.
David Rowitch, a developmental neuroscientist at the University of Cambridge, explains that these cells simply don’t handle extra stress well, leading to the cell death that characterizes the progressive shrinking of the brain.
Shifting the Treatment Paradigm
Currently, most MS therapies focus on tamping down the immune system to reduce inflammation or attempting to restore myelin to nerve fibers. However, as Steve Fancy points out, there is currently no effective treatment for the progressive phase where neurons actually die.
This discovery suggests that treating the inflammation alone isn’t enough. To stop cognitive decline, medicine must address the “intrinsic vulnerabilities” of the nerve cells themselves. Don Mahad, a neurologist at the University of Edinburgh, emphasizes that these internal weaknesses must become a primary treatment target.
The Path Forward
With approximately 10,000 people diagnosed with MS every year in the United States, the need for neuroprotective therapies is urgent. While the discovery of the CUX2-ATF4 link is only the beginning of a long journey, it provides a concrete biological target for future drug development.
By designing treatments that bolster the DNA repair mechanisms of vulnerable neurons, scientists hope to move beyond managing flare-ups and toward a future where the cognitive functions of MS patients can be fully preserved.
Frequently Asked Questions
What is the difference between relapsing and progressive MS?
Early stages of MS often involve inflammation and the loss of myelin (insulation) around nerve fibers, leading to unpredictable flare-ups of pain and muscle weakness. In the progressive phase, the disease moves beyond the myelin to the neurons themselves, causing brain cells to die and the brain to shrink, which leads to sharper declines in memory and reasoning.
What are CUX2 neurons?
CUX2 neurons are specialized brain cells located in the human cortex. They are primarily responsible for the cognitive and computational functions that allow humans to perform complex mental tasks.
Why is ATF4 important?
ATF4 is a protein that triggers the DNA repair response in CUX2 neurons. Without it, these cells cannot repair the damage caused by their rapid multiplication during development, making them much more likely to die when stressed by diseases like MS.